LifeStance Health Group (LFST) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on LifeStance Health Group (LFST) is Neutral.

The composite score behind that read is -0.18, weighing +0.22 of bullish evidence against -0.29 bearish.

LifeStance Health Group last closed at $12.12, -0.82% on the session.

Against the IVW growth benchmark the position is -1.43% over the forecast window.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

17 graded predictions for LFST so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks LifeStance Health Group in the 7th percentile on valuation and the 45th percentile on return on equity, where 100 is best.

LifeStance Health Group is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $4.67B.

StockMap tracks LifeStance Health Group as the 29th largest of the 80 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Neutral and 26 Moderate Underperform.

On that composite LifeStance Health Group ranks 52nd of 80 in the group, against a group median of -0.13.